1.Suanzaoren Tang Regulates SP1/SK1/S1PR1 Signaling Pathway to Reduce Hippocampal Neuroinflammation and Improve Synaptic Plasticity in Rat Model of Depression
Jianyu FENG ; Wenhua WANG ; Youwen WANG ; Ying TAN ; Xusheng TIAN
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(21):1-10
ObjectiveTo evaluate the effect of Suanzaoren Tang on the rat model of depression established by solitary culture combined with chronic unpredictable mild stress by reshaping the inflammatory microenvironment and mediating changes in hippocampal synaptic plasticity. MethodsSeventy-two male SD rats were randomized by a random number table into six groups: control group, model group, fluoxetine group (0.003 6 g·kg-1), and high-(10 g·kg-1), medium-(5 g·kg-1), low-dose (2.5 g·kg-1)Suanzaoren Tang groups, with 12 rats per group. The sucrose preference rate and open field test scores of rats in each group were observed. Western blot was employed to determine the expression levels of the key proteins in the specificity protein 1 (SP1)/sphingosine kinase 1 (SK1)/sphingosine-1-phosphate receptor 1 (S1PR1) signaling pathway, as well as hippocampal proteins synaptophysin Ⅰ (SYNⅠ), postsynaptic density protein-95 (PSD-95), and family with sequence similarity 19, member A5 (FAM19A5). Immunohistochemistry was employed to detect the positive expression of SP1, PSD-95, SYNⅠ, interleukin (IL)-10, and IL-6. Real-time fluorescence quantitative polymerase chain reaction (Real-time PCR) was employed to determine the mRNA levels of SP1 and S1PR1. Finally, transmission electron microscopy was employed to observe the ultrastructural changes of hippocampal synapses. ResultsCompared with the control group, the model group exhibited a decrease in sucrose preference index (P<0.01) and reduced total scores for horizontal and vertical movements in the open field test (P<0.01), which indicated the successful modeling of depression. Moreover, the model group showed reduced synaptic vesicles in the hippocampus (P<0.01), up-regulated expression of SP1, SK1, S1PR1, and IL-6 (P<0.01), and down-regulated expression of SYNⅠ, PSD-95, FAM19A5, and IL-10 (P<0.01). Compared with the model group, high- and medium-dose Suanzaoren Tang and fluoxetine increased the sucrose preference index and the total scores for horizontal and vertical movements in the open field test (P<0.01). All Suanzaoren Tang groups and the fluoxetine group demonstrated reductions in SP1, SK1, S1PR1, and IL-6 expression (P<0.05, P<0.01), alongside restored synaptic vesicles in the hippocampus (P<0.05, P<0.01). ConclusionSuanzaoren Tang modulates hippocampal expression of FAM19A5, SYNⅠ, PSD-95, IL-10, IL-6, and the SP1/SK1/S1PR1 pathway in the rat model of depression. The antidepressant effects may be related to the ability of reducing neuroinflammation and enhancing synaptic plasticity.
2.Suanzaoren Tang Regulates SP1/SK1/S1PR1 Signaling Pathway to Reduce Hippocampal Neuroinflammation and Improve Synaptic Plasticity in Rat Model of Depression
Jianyu FENG ; Wenhua WANG ; Youwen WANG ; Ying TAN ; Xusheng TIAN
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(21):1-10
ObjectiveTo evaluate the effect of Suanzaoren Tang on the rat model of depression established by solitary culture combined with chronic unpredictable mild stress by reshaping the inflammatory microenvironment and mediating changes in hippocampal synaptic plasticity. MethodsSeventy-two male SD rats were randomized by a random number table into six groups: control group, model group, fluoxetine group (0.003 6 g·kg-1), and high-(10 g·kg-1), medium-(5 g·kg-1), low-dose (2.5 g·kg-1)Suanzaoren Tang groups, with 12 rats per group. The sucrose preference rate and open field test scores of rats in each group were observed. Western blot was employed to determine the expression levels of the key proteins in the specificity protein 1 (SP1)/sphingosine kinase 1 (SK1)/sphingosine-1-phosphate receptor 1 (S1PR1) signaling pathway, as well as hippocampal proteins synaptophysin Ⅰ (SYNⅠ), postsynaptic density protein-95 (PSD-95), and family with sequence similarity 19, member A5 (FAM19A5). Immunohistochemistry was employed to detect the positive expression of SP1, PSD-95, SYNⅠ, interleukin (IL)-10, and IL-6. Real-time fluorescence quantitative polymerase chain reaction (Real-time PCR) was employed to determine the mRNA levels of SP1 and S1PR1. Finally, transmission electron microscopy was employed to observe the ultrastructural changes of hippocampal synapses. ResultsCompared with the control group, the model group exhibited a decrease in sucrose preference index (P<0.01) and reduced total scores for horizontal and vertical movements in the open field test (P<0.01), which indicated the successful modeling of depression. Moreover, the model group showed reduced synaptic vesicles in the hippocampus (P<0.01), up-regulated expression of SP1, SK1, S1PR1, and IL-6 (P<0.01), and down-regulated expression of SYNⅠ, PSD-95, FAM19A5, and IL-10 (P<0.01). Compared with the model group, high- and medium-dose Suanzaoren Tang and fluoxetine increased the sucrose preference index and the total scores for horizontal and vertical movements in the open field test (P<0.01). All Suanzaoren Tang groups and the fluoxetine group demonstrated reductions in SP1, SK1, S1PR1, and IL-6 expression (P<0.05, P<0.01), alongside restored synaptic vesicles in the hippocampus (P<0.05, P<0.01). ConclusionSuanzaoren Tang modulates hippocampal expression of FAM19A5, SYNⅠ, PSD-95, IL-10, IL-6, and the SP1/SK1/S1PR1 pathway in the rat model of depression. The antidepressant effects may be related to the ability of reducing neuroinflammation and enhancing synaptic plasticity.
3.Analysis of clinical value of platelet antibody screening in 95 987 inpatients.
Ping CHEN ; Yang SUN ; Xiaoyue CHU ; Fenfang TIAN ; Yingqun YANG ; Wenhua WANG ; Jiameng NIU ; Boya ZHAO ; Jingyan CHANG ; Jiangcun YANG ; Chaofeng MA
Chinese Journal of Cellular and Molecular Immunology 2025;41(2):143-147
Objective To analyze the distribution of platelet antibodies in hospitalized patients and explore the clinical significance of platelet antibody detection. Methods A total of 95 987 hospitalized patient cases from a tertiary hospital in Xi'an from April 1, 2021 to December 31, 2023 were collected. Platelet antibodies were detected by solid-phase agglutination method. Statistical analysis was performed on variables including gender, age, blood type, department, history of blood transfusion, pregnancy history, and disease type. Results Among 95 987 hospitalized patients, the positive rate of platelet antibody detection reached 4.35%. The positive rate of platelet antibodies in female hospitalized patients (5.29%) was higher than that in male patients (3.31%), and the difference was statistically significant (x2=224.124). The positive rate of platelet antibodies in those with pregnancy history (7.92%) was higher than that in those without pregnancy history (4.19%), and the difference was significant (x2=292.773). Similarly, the positive rate of platelet antibodies in those with transfusion history (7.79%) was higher than that in those without transfusion history (3.97%), and the difference was significant (x2=300.209). There was a significant correlation between the positive rate of platelet antibodies and the number of pregnancies (x2=91.061). Conclusion The positive rate of platelet antibodies in 95 987 inpatient cases was 4.35%. The positive rate of platelet antibodies had a close relationship with a history of blood transfusions and pregnancies, and it increased with the number of pregnancies. For patients with multiple transfusion histories and pregnancy histories, screening for platelet antibodies holds significant diagnostic value.
Humans
;
Female
;
Male
;
Adult
;
Middle Aged
;
Blood Platelets/immunology*
;
Inpatients
;
Aged
;
Pregnancy
;
Young Adult
;
Adolescent
;
Aged, 80 and over
;
Autoantibodies/blood*
4.Discovery and proof-of-concept study of a novel highly selective sigma-1 receptor agonist for antipsychotic drug development.
Wanyu TANG ; Zhixue MA ; Bang LI ; Zhexiang YU ; Xiaobao ZHAO ; Huicui YANG ; Jian HU ; Sheng TIAN ; Linghan GU ; Jiaojiao CHEN ; Xing ZOU ; Qi WANG ; Fan CHEN ; Guangying LI ; Chaonan ZHENG ; Shuliu GAO ; Wenjing LIU ; Yue LI ; Wenhua ZHENG ; Mingmei WANG ; Na YE ; Xuechu ZHEN
Acta Pharmaceutica Sinica B 2025;15(10):5346-5365
Sigma-1 receptor (σ 1R) has become a focus point of drug discovery for central nervous system (CNS) diseases. A series of novel 1-phenylethan-1-one O-(2-aminoethyl) oxime derivatives were synthesized. In vitro biological evaluation led to the identification of 1a, 14a, 15d and 16d as the most high-affinity (K i < 4 nmol/L) and selective σ 1R agonists. Among these, 15d, the most metabolically stable derivative exhibited high selectivity for σ 1R in relation to σ 2R and 52 other human targets. In addition to low CYP450 inhibition and induction, 15d also exhibited high brain permeability and excellent oral bioavailability. Importantly, 15d demonstrated effective antipsychotic potency, particularly for alleviating negative symptoms and improving cognitive impairment in experimental animal models, both of which are major challenges for schizophrenia treatment. Moreover, 15d produced no significant extrapyramidal symptoms, exhibiting superior pharmacological profiles in relation to current antipsychotic drugs. Mechanistically, 15d inhibited GSK3β and enhanced prefrontal BDNF expression and excitatory synaptic transmission in pyramidal neurons. Collectively, these in vivo proof-of-concept findings provide substantial experimental evidence to demonstrate that modulating σ 1R represents a potential new therapeutic approach for schizophrenia. The novel chemical entity along with its favorable drug-like and pharmacological profile of 15d renders it a promising candidate for treating schizophrenia.
5.Application effect of combined traction methods in endoscopic submucosal dissection for early intestinal lesions
Chengcheng ZHU ; Yalong HE ; Jing TIAN ; Wei ZHANG ; Min XU ; Zhihua WANG ; Ping CHEN ; Wenhua ZHANG
Chongqing Medicine 2025;54(6):1307-1311,1318
Objective To investigate the application effect of postural gravity traction combined with floss and titanium clip pulley external traction in endoscopic submucosal dissection(ESD)for early intestinal lesions.Methods A total of 100 patients with early colorectal lesions admitted to the Affiliated Hospital of Jiangsu University from January 2022 to September 2024 were selected as the research subjects and divided in-to the observation group and the control group,with 50 cases in each group.The control group underwent con-ventional intestinal ESD treatment,while the observation group used positional gravity traction combined with dental floss and titanium clips to form pulley external traction in ESD treatment.Clinical data including opera-tion time,number of submucosal injections,intraoperative blood loss,lesion resection effect,complication inci-dence,and hospital stay were compared between the two groups.Results The total operation time in the ob-servation group was shorter than that in the control group,and the total number of submucosal injections was less than that in the control group,with statistically significant differences(P<0.05).There were no signifi-cant differences in intraoperative blood loss,complete resection rate,complication incidence,en bloc resection rate,and hospital stay between the two groups(P>0.05).For lesions≤1 cm or>5 cm in size,there were no significant differences in operation time,complete resection rate and en bloc resection rate between the two groups(P>0.05).For lesions>1-3 cm or>3-5 cm in size and laterally spreading lesions,significant differences were observed in operation time,number of submucosal injections,complete resection rate,and en bloc resection rate between the two groups(P<0.05).For pedunculated polyps,there were no significant differences in the number of submucosal injections,complete resection rate and en bloc resection rate between the two groups(P>0.05),but the operation time differed significantly(P<0.05).Conclusion Postural gravity traction combined with dental floss and titanium clip to form pulley external traction is simple to oper-ate in ESD for early intestinal lesions.It can maintain a clear field of view,shorten operation time,reduce the incidence of complications,and is safe and effective.
6.Expert consensus on pediatric orthodontic therapies of malocclusions in children
Zhou CHENCHEN ; Duan PEIPEI ; He HONG ; Song JINLIN ; Hu MIN ; Liu YUEHUA ; Liu YAN ; Guo JIE ; Jin FANG ; Cao YANG ; Jiang LINGYONG ; Ye QINGSONG ; Zhu MIN ; Jiang BEIZHAN ; Ruan WENHUA ; Yuan XIAO ; Li HUANG ; Zou RUI ; Tian YULOU ; Gao LI ; Shu RUI ; Chen JIANWEI ; Liu RENKAI ; Zou SHUJUAN ; Li XIAOBING
International Journal of Oral Science 2024;16(2):186-196
Malocclusion,identified by the World Health Organization(WHO)as one of three major oral diseases,profoundly impacts the dental-maxillofacial functions,facial esthetics,and long-term development of~260 million children in China.Beyond its physical manifestations,malocclusion also significantly influences the psycho-social well-being of these children.Timely intervention in malocclusion can foster an environment conducive to dental-maxillofacial development and substantially decrease the incidence of malocclusion or reduce the severity and complexity of malocclusion in the permanent dentition,by mitigating the negative impact of abnormal environmental influences on the growth.Early orthodontic treatment encompasses accurate identification and treatment of dental and maxillofacial morphological and functional abnormalities during various stages of dental-maxillofacial development,ranging from fetal stages to the early permanent dentition phase.From an economic and societal standpoint,the urgency for effective early orthodontic treatments for malocclusions in childhood cannot be overstated,underlining its profound practical and social importance.This consensus paper discusses the characteristics and the detrimental effects of malocclusion in children,emphasizing critical need for early treatment.It elaborates on corresponding core principles and fundamental approaches in early orthodontics,proposing comprehensive guidance for preventive and interceptive orthodontic treatment,serving as a reference for clinicians engaged in early orthodontic treatment.
7.Nursing expert consensus on subcutaneous injection for allergen-specific immunotherapy
Allergy and Clinical Immunology Committee of Chinese Research Hospital Association ; Allergy Care Group,Chinese Society of Allergology,Chinese Medical Association ; Allergy Prevention and Control Committee of Chinese Preventive Medicine Association ; Qing WANG ; Jun LIU ; Fan ZHI ; Wenjin WAN ; Fengying TIAN ; Xiaopeng HUO ; Wenhua ZHOU ; Yongshi YANG ; Tiantian WANG ; Jinlü SUN
Chinese Journal of Nursing 2024;59(9):1080-1084
Objective To develop an expert consensus on subcutaneous injection for allergen-specific immunotherapy.Methods Relevant domestic and intemational literature was reviewed,and nursing experts who had experiences in subcutaneous injection of allergen-specific immunotherapy were interviewed to form the initial draft of the consensus.A total of 85 experts from 42 hospitals nationwide were invited to participate in discussions.2 rounds of expert consultations,adjustments,revisions,and improvements were made to the initial draft,and an online meeting was held to form the final version of the consensus.The content approved by more than 75%of the expert group is adopted,or it will be discussed or deleted.Results The expert consensus includes operational standards for subcutaneous injection of allergen-specific immunotherapy,identification and management of adverse reactions,and health education.Conclusion The consensus demonstrates strong scientific rigor and practicality,providing guidance for nursing practices in the field of clinical allergology.
8.Removal, detection, and limits of endotoxin in the industry of recombinant proteins.
Shuyan LIU ; Wenhua TIAN ; Ling LI ; Hong ZHANG ; Jian WANG ; Yufeng YU
Chinese Journal of Biotechnology 2024;40(11):4006-4018
With the advancement of synthetic biology, recombinant proteins are poised to play a significant role in medical applications. The scaled manufacturing is a pillar for the extensive application and development of recombinant proteins across various fields. In the large-scale production process of recombinant proteins, the removal and detection of endotoxins are essential to reduce their levels to safe thresholds in the final products. Currently, establishing stringent endotoxin limits for different recombinant protein products is a crucial aspect of safety assessment. This review begins by shedding light on the pathogenicity of endotoxins and discusses the methods for the removal and determination of endotoxins during the production processes of recombinant proteins. Subsequently, this review summarizes the endotoxin limits in industries such as biologics, medical devices, and human recombinant DNA products, particularly those in recombinant protein injection products. It is highlighted that regardless of whether the hosts for recombinant protein expression are bacteria or not, endotoxin testing is required for the final products of injectable recombinant proteins, and compliance with relevant industry standards is necessary. This review aims to provide a reference for the research on endotoxins in the large-scale production process of recombinant proteins.
Endotoxins/genetics*
;
Recombinant Proteins/genetics*
;
Humans
;
Drug Contamination/prevention & control*
9.Effects of Bushen ovulation-stimulating decoction on oocyte quality and pregnancy outcome of IVF-ET in patients with repeated transplantation failure
Yangyang CUI ; Feng TIAN ; Wenhua WANG
Journal of Navy Medicine 2024;45(1):76-80
Objective To explore the effects of Bushen ovulation-stimulating decoction on oocyte quality and pregnancy outcome of in vitro fertilization-embryo transfer(IVF-ET)in patients with repeated transplantation failure.Methods From January 2019 to January 2021,86 patients who received IVF-ET again because of repeated transplantation failure in Jinzhong Yingtai Women's&Children's Hospital were randomly divided into control group and observation group,with 43 cases in each group.Progesterone was given 2 days before IVF-ET treatment in both groups,and the observation group was additionally treated with Bushen ovulation-stimulating decoction at the peak of luteinizing hormone in menstrual cycle before transplantation.All the patients in both groups were treated continuously for 3 menstrual cycles.Traditional Chinese medicine symptom score,hormone level,oocyte quality,endometrium and blood flow were observed and compared between the 2 groups.Results After 3 menstrual cycles of treatment,the scores of pale menstrual color,soreness and softness of waist and knees,and dryness in the vagina in the observation group were significantly lower than those in the control group(P<0.05).Three weeks after transplant,the observation group had significantly higher levels of serum progesterone(P)and estradiol(E2)and lower level of follicle stimulating hormone(FSH)than the control group(all P<0.05).On the day of ovulation,the thickness of endometrium in the observation group was significantly higher than that in the control group,and the resistance index(RI)and pulsatility index(PI)of uterine artery in the observation group were significantly lower than those in the control group(P<0.05).The fertilization rate,the number of ovum obtained,clinical pregnancy rate,average gestational weeks of delivery,neonatal weight and one-minute Apgar score in the observation group were significantly higher than those in the control group(P<0.05).The early abortion rate and fetal preterm birth rate in the observation group were significantly lower than those in the control group(P<0.05).Conclusion Bushen ovulation-stimulating decoction can significantly increase the scores of traditional Chinese medicine symptoms,improve blood circulation of uterus,gonadal hormone concentrations and oocyte quality,and reduce the incidence of adverse pregnancy outcomes in patients who repeatedly fail to receive IVF-ET treatment.
10.Chinese expert consensus on clinical treatment of adult patients with severe traumatic brain injury complicated by corona virus disease 2019 (version 2023)
Zeli ZHANG ; Shoujia SUN ; Yijun BAO ; Li BIE ; Yunxing CAO ; Yangong CHAO ; Juxiang CHEN ; Wenhua FANG ; Guang FENG ; Lei FENG ; Junfeng FENG ; Liang GAO ; Bingsha HAN ; Ping HAN ; Chenggong HU ; Jin HU ; Rong HU ; Wei HE ; Lijun HOU ; Xianjian HUANG ; Jiyao JIANG ; Rongcai JIANG ; Lihong LI ; Xiaopeng LI ; Jinfang LIU ; Jie LIU ; Shengqing LYU ; Binghui QIU ; Xizhou SUN ; Xiaochuan SUN ; Hengli TIAN ; Ye TIAN ; Ke WANG ; Ning WANG ; Xinjun WANG ; Donghai WANG ; Yuhai WANG ; Jianjun WANG ; Xingong WANG ; Junji WEI ; Feng XU ; Min XU ; Can YAN ; Wei YAN ; Xiaofeng YANG ; Chaohua YANG ; Rui ZHANG ; Yongming ZHANG ; Di ZHAO ; Jianxin ZHU ; Guoyi GAO ; Qibing HUANG
Chinese Journal of Trauma 2023;39(3):193-203
The condition of patients with severe traumatic brain injury (sTBI) complicated by corona virus 2019 disease (COVID-19) is complex. sTBI can significantly increase the probability of COVID-19 developing into severe or critical stage, while COVID-19 can also increase the surgical risk of sTBI and the severity of postoperative lung lesions. There are many contradictions in the treatment process, which brings difficulties to the clinical treatment of such patients. Up to now, there are few clinical studies and therapeutic norms relevant to sTBI complicated by COVID-19. In order to standardize the clinical treatment of such patients, Critical Care Medicine Branch of China International Exchange and Promotive Association for Medical and Healthcare and Editorial Board of Chinese Journal of Trauma organized relevant experts to formulate the Chinese expert consensus on clinical treatment of adult patients with severe traumatic brain injury complicated by corona virus infection 2019 ( version 2023) based on the joint prevention and control mechanism scheme of the State Council and domestic and foreign literatures on sTBI and COVID-19 in the past 3 years of the international epidemic. Fifteen recommendations focused on emergency treatment, emergency surgery and comprehensive management were put forward to provide a guidance for the diagnosis and treatment of sTBI complicated by COVID-19.

Result Analysis
Print
Save
E-mail